LPL Financial
AUTL

LPL Financial’s Autolus Therapeutics AUTL Stock Holding History

LPL Financial’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Buy
42,625
+5,000
+13% +$7.84K ﹤0.01% 5986
2026
Q1 		$51.9K Sell
37,625
-5,000
-12% -$7.59K ﹤0.01% 5781
2025
Q4 		$84.8K Sell
42,625
-91,400
-68% -$140K ﹤0.01% 5638
2025
Q3 		$218K Buy
134,025
+100,400
+299% +$196K ﹤0.01% 5288
2025
Q2 		$76.7K Buy
33,625
+2,750
+9% +$4.55K ﹤0.01% 5310
2025
Q1 		$47.9K Sell
30,875
-5,850
-16% -$11.9K ﹤0.01% 5159
2024
Q4 		$86.3K Buy
36,725
+850
+2% +$2.87K ﹤0.01% 5019
2024
Q3 		$130K Buy
35,875
+2,290
+7% +$9.13K ﹤0.01% 4836
2024
Q2 		$117K Sell
33,585
-984
-3% -$4.25K ﹤0.01% 4708
2024
Q1 		$221K Sell
34,569
-5,975
-15% -$37.3K ﹤0.01% 4440
2023
Q4 		$261K Buy
40,544
+219
+0.5% +$835 ﹤0.01% 4201
2023
Q3 		$94K Sell
40,325
-8,350
-17% -$23.8K ﹤0.01% 4435
2023
Q2 		$116K Buy
48,675
+13,350
+38% +$31.7K ﹤0.01% 4299
2023
Q1 		$65K Buy
35,325
+3,025
+9% +$5.91K ﹤0.01% 4276
2022
Q4 		$61.4K Buy
32,300
+9,100
+39% +$23K ﹤0.01% 4239
2022
Q3 		$50K Buy
+23,200
New +$68.7K ﹤0.01% 4229

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LPL Financial's AUTL Position: Q2 2026 in Review

LPL Financial increased its Autolus Therapeutics (AUTL) stake by 13% in Q2 2026, buying an estimated $7.84K and bringing the position to 42,625 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5986.

LPL Financial first reported a position in AUTL in Q3 2022 and has held it in 16 quarters since. The position peaked at $261K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • LPL Financial held 42,625 shares of Autolus Therapeutics worth $68.2K as of Q2 2026.
  • LPL Financial bought 5,000 Autolus Therapeutics shares in Q2 2026, an estimated $7.84K.
  • Autolus Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5986 holding.
  • LPL Financial first reported a position in Autolus Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • LPL Financial's Autolus Therapeutics position peaked at $261K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.